Israel Englander’s Royalty Pharma RPRX Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$381K Buy
+6,800
New +$354K ﹤0.01% 4966
2025
Q2
Sell
-567,400
Closed -$17.7M 6266
2025
Q1
$17.7M Buy
+567,400
New +$18M 0.01% 1651

Other funds holding RPRX

Israel Englander's RPRX Position: Q2 2026 in Review

Israel Englander opened a new position in Royalty Pharma (RPRX) in Q2 2026: 12,043 shares worth $675K. The stake represents ﹤0.01% of the portfolio and ranks #4575 among its holdings. This is a return to the name: Israel Englander previously reported a position in RPRX as recently as Q4 2025.

Israel Englander first reported a position in RPRX in Q2 2020 and has held it in 23 quarters since. The position peaked at $142M in Q1 2024. 640 funds tracked by Wall St. Rank hold RPRX as of Q2 2026.

  • Israel Englander held 12,043 shares of Royalty Pharma worth $675K as of Q2 2026.
  • Royalty Pharma was a new Israel Englander position in Q2 2026.
  • Royalty Pharma made up ﹤0.01% of Israel Englander's portfolio in Q2 2026, its #4575 holding.
  • Israel Englander first reported a position in Royalty Pharma in Q2 2020 and has held it in 23 quarters since.
  • Israel Englander's Royalty Pharma position peaked at $142M in Q1 2024.
  • 640 funds tracked by Wall St. Rank held Royalty Pharma as of Q2 2026.

Based on Millennium Management's 13F filing for Q2 2026, filed 14 Aug 2026.